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ABSTRAK
Tujuan: mengetahui kemampuan heart rate variability (HRV) yang diukur melalui metode pulse 
photoplethysmograph (PPG) dalam memprediksi major adverse cardiac event (MACE) pada pasien sindrom 
koroner akut (SKA). Metode: studi kohort prospektif dilakukan pada pasien SKA yang menjalani perawatan 
di ICCU.  Pemeriksaan HRV dengan metode PPG dilakukan dalam 48 jam pertama perawatan dan kejadian 
MACE diidentifikasi selama perawatan di ICCU. Kemampuan HRV dalam memprediksi MACE selama perawatan 
dinilai dengan menghitung area under ROC curve (AUC) dari parameter low frequency (LF), high fequency 
(HF), dan rasio LF/HF. Hasil: dari 75 subyek penelitian, 14 (18.7%) di antaranya mengalami MACE selama 
perawatan. Parameter HRV berupa LH memiliki AUC 0,697 (IK95% 0.543-0,850) dan rasio LF/HF memiliki 
AUC 0.851 (0,741-0,962). Dengan menggunakan titik potong 89.673 ms2, LF memiliki nilai duga positif (NDP) 
sebesar 13% dan nilai duga negatif (NDN) sebesar 71%, sementara dengan dengan titik-potong 1.718 rasio LF/
HF memiliki NDP 6% dan NDN 50%. Kesimpulan: parameter HRV berupa LF dan rasio LF/HF merupakan 
prediktor yang cukup baik terhadap MACE, terutama dalam memprediksi pasien pasca SKA yang tidak akan 
mengalami MACE selama perawatan.
Kata kunci: sindrom koroner akut, heart rate variability, major adverse cardiac events, pulse 
photoplethysmograph.
ABSTRACT
Aim: to assess heart rate variability (HRV) measurements using pulse photoplethysmograph (PPG) in predicting 
major adverse cardiac event (MACE) in acute coronary syndrome (ACS) patients. Methods: a prospective cohort 
study was conducted among hospitalized ACS patients. Heart rate variability as predictor was measured by PPG 
within 48 hours after admission and the incidence of MACE as outcome was identified during ICCU stay. The 
ability of HRV in predicting MACE during hospitalization was determined by area under ROC curve (AUC) of 
low frequency (LF), high fequency (HF), and LF/HF ratio parameters. Results: among 75 subjects included in the 
study, 14 (18.7%) were experienced MACE during hospitalization. HRV parameters of LF and LF/HF ratio have 
AUC of 0.697 (95% CI, 0.543-0.850) and 0.851 (0.741-0.962), respectively. Using cut-off point of 89.673 ms2, 
LF had PPV and NPV of 13% and 71%, respectively; while LF/HF ratio of 1.718 had PPV and NPV of 6% and 
50%, respectively. Conclusion: the HRV parameters of LF and LF/HF ratio are moderate predictors for MACE 
and predict better ACS patients who will not develop MACE during hospitalization.
Keywords: acute coronary syndrome, heart rate variability, major adverse cardiac events, pulse 
photoplethysmograph.
Vol 48 • Number 1 • January 2016                         The ability of heart rate variability with photoplethysmograph method
49
INTRODUCTION
Data from World Health Organization (WHO) 
shows that heart disease is the main cause of death 
globally. It is responsible for 30% of total deaths 
across the world.1 In Indonesia, the prevalence 
of heart disease diagnosed by health providers is 
7.2% of population with coronary heart disease 
in 1.5%.2 Survei Kesehatan Rumah Tangga 
(SKRT) also indicated a rise in cardiovascular 
mortality, which is mainly instigated by coronary 
heart disease with more than 1.5 times increase 
in prevalence in just a decade (16% in 1992 
to 26.9% by 2001).3 Nevertheless, prevention 
of mortality and morbidity in acute coronary 
syndrome (ACS) is hard to be achieved due to 
its various complications, ranging from mechanic 
complications such as ventricular rupture and 
mitral regurgitation to electrical complications/
arrhythmia.4-6
Several studies have shown that heart rate 
variability (HRV), defined as fluctuation of 
heart rate frequency around its mean value, is 
an independent prognostic factor for long-term 
mortality/morbidity in post-ACS patients.7-13 The 
HRV measurement is non-invasive and real time, 
thus it is suitable for intensive hemodynamic 
monitoring. To date, HRV measurement can be 
done by pulse photoplethysmography (PPG) 
method with finger plethysmogram (FPG) 
which only needs 2-30 minutes to complete the 
measurement but yields a very similar result from 
Holter ECG measurement.14-17
Although the use of HRV measurement using 
PPG method as prognostic factor for long-term 
mortality and morbidity after ACS has been 
widely studied, its use in predicting in-hospital 
outcomes is limited. As the technique becomes 
more practical, HRV measurements using PPG 
method, is expected to be a routine non-invasive 
modality in assessing post-ACS risks in addition 
to well-established risk prediction models. 
Therefore, we conducted this study to assess 
HRV ability with PPG method in predicting 
major adverse cardiac events (MACE) during 
hospitalization in ACS patients.
METHODS
Design, Setting, and Patients
A prospective cohort study was conducted 
among adult ACS patients admitted to Intensive 
Cardiac Care Unit (ICCU) from September to 
November. Acute coronary syndrome (ACS) 
was diagnosed based on typical chest pain 
complaint, increase in cardiac marker enzymes, 
and ECG changes, by the physician-in-charge 
after a consultation to cardiologist. Patients 
were excluded if they were admitted to ICCU 
more than 48 hours after ACS diagnosis in 
Emergency Unit and were having MACE before 
HRV measurement. Patients were dropped out 
if they did not comply with the measurement 
protocol, withdrew from the study, or died from 
unrelated causes.
Eligible subjects were asked for their written 
consent before included in the study. The study 
protocol has been reviewed and approved by 
Medical Research Ethics Committee Faculty 
of Medicine Universitas Indonesia/Cipto 
Mangunkusumo Hospital.
Baseline Data and HRV Measurements
On the first day of admission, demographic 
and clinical data was obtained from all subjects 
including types of ACS, risk factors, previous 
cardiovascular events, and, if available, coronary 
vessels involvement. The heart rate variability 
was measured using photoplethysmography 
(PPG) method during first 48 hours after 
diagnosis. The variables of PPG method 
including low frequency (LF), high frequency 
(HF), LF/HF ratio, standard deviation of normal-
to-normal interval (SDNN), and square root of 
mean squared differences of consecutive normal-
to-normal intervals (RMSSD).
Assessment of Outcomes
All subjects were followed up during their 
stay in ICCU and were determined whether 
they experienced major adverse cardiac events 
(MACE), i.e. fatal arrhythmia, acute heart failure, 
cardiogenic shock, re-infarction, and mechanic 
complications (such as valve abnormalities or 
myocardium rupture). Confirmation regarding 
MACE diagnosis was done by principal 
investigator and supervisor of ICCU.
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Statistical Analysis 
Minimal subjects required for this study was 
calculated using formula for determining area 
under the curve (AUC). Subjects’ characteristics 
were presented descriptively in a baseline table 
according types of data. MACE incidence was 
presented in mean of proportion. The abilities 
of HRV to predict MACE were determined by 
AUC values of SDNN, RMSSD, LF, HF, and 
LF/HF ratio. Cut-off of HRV parameters with 
favorable prediction value (AUC >50% and 95% 
CI excluded 0.5) and were further presented as 
positive predictive value (PPV) and negative 
predictive value (NPV) based on the cut-off 
values according to the optimal sensitivities and 
specificities.
RESULTS
There were 101 ACS patients admitted to 
ICCU during the study period and 26 were 
excluded because of earlier MACE before HRV 
measurement, resulting 75 subjects included in 
this study, with mean age of 58.7 (11.5) years 
old and predominantly male (69.3%). Unstable 
angina pectoris (UAP) and Non ST-Elevation 
Myocard Infarction (NSTEMI) were most 
common diagnosis, while hypertension was the 
most common risk factors followed by diabetes 
and hypercholesterolemia. (Table 1)
Subjects admitted to ICCU <48 hours post-
diagnosis were studied and the median of HRV 
measurement for each parameter is presented 
in Table 2.
Mean length of ICCU stay in all subjects 
was 6.7 (SD 3.1) days. During hospitalization, 
MACEs were occured in 14 (18.7%) subjects; 
nine of them were found in STEMI subjects. 
Almost (93%) all of those events occurred in 
the first two days of ICCU admission (mean 
duration 1.1 days). Proportion of each events is 
presented in Table 3.
Parameters of HRV with the best AUC 
were LF and LF/HF ratio (Table 4). Both of the 
parameters were then assessed for their risk cut-
off points. For LF and LF/HF ratio, the cut-off 
were 89.673 ms2 and 1.718, respectively.
Both parameters were then converted into 
categorical data to determine their positive 
predictive values (PPV) and negative predictive 
Table 1. Subjects’ characteristics
Characteristics Total (N=75)
Age (years), mean (SD) 58.7 (11.5)
Male, n (%) 52 (693)
Length of stay in ICCU (days), mean 
(SD) 67 (31)
ACS subtype, n (%)
 - UAP 29 (38.7)
 - NSTEMI 28 (37.3)
 - STEMI 18 (24.0)
Anterior infarction, n (%) 53 (70.7)
TIMI score, mean (SD) 3,4 (1.7)
Hypertension, n (%) 49 (65.3)
Systolic blood pressure (mmHg), 
mean (SD) 125.1 (19.7)
Diastolic blood pressure, mmHg 
(mean (SD)) 70.5 (12.4)
Diabetes, n (%) 31 (41.3)
HbA1c (%), mean (SD) 7.7 (1.8)
Hypercholesterolemia, n (%) 25 (33.3)
LDL (mg/dL), mean (SD) 116.8 (45.1)
LVEF (%), mean (SD) 49.4 (14.5)
Smoking, n (%) 36 (48)
Previous myocardial infarction, n (%) 36 (48)
Previous stroke, n (%) 6 (8)
History of revascularization, n (%) 12 (16)
 - percutaneous coronary intervention 9 (12)
 - coronary artery bypass grafting 3 (4)
Coronary artery involvement, n (%)
 - Single-vessel disease 22 (29.3)
 - 2-vessel disease 17 (22.7)
 - 3-vessel disease 36 (48)
ACS=acute coronary syndome; HbA1c=glycated 
hemoglobin; ICCU=intensive cardiac care unit; LDL=low-
density lipoprotein; LVEF= left ventricular ejection fraction; 
NSTEMI=Non ST-elevation myocard infarction; STEMI= 
ST-elevation myocard infarction; TIMI=Thrombolysis in 
Myocard Infarction; UAP=unstable angina pectoris
Tabel 2. Subjects’ HRV measurement
Parameter Median  (Interquartile range)
Mean HR, times per minute 75 (20)
SDNN (ms) 24268 (21332)
RMSSD (ms) 25450 (23787)
LF (ms2) 63644 (131822)
HF (ms2) 74714 (124271)
Rasio LF/HF 0915 (1571)
HF=high frequency (HF); HR=heart rate; LF=low frequency; 
ms=miliseconds; RMSSD=square root of mean squared 
differences of consecutive normal-to-normal intervals; 
SDNN=standard deviation of normal-to-normal interval
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values (NPV). The PPV and NPV of LF were 
13% (CI 95%, 3 to 22%) and 71% (CI 95%, 55 
to 88%), respectively; while PPV and NPV of 
LF/HF ratio were 6% (CI 95% -1 to 12%) and 
50% (CI 95% 25 to 71%), respectively.
DISCUSSION
To our knowledge, this was the first study 
which assessed the ability of HRV measurement 
using PPG method to predict MACE during 
hospitalization in ACS patients. We found that the 
HRV parameters measured in the first 48-hours of 
hospitalization were lower than those of normal 
population stated by Task Force of the European 
Society of Cardiology and the North American 
Society of Pacing and Electrophysiology. The 
Task Force found the mean values of SDNN, 
RMSSD, LF, HF, and LF/HF ratio in normal 
population were 141 ms, 27 ms, 1170 Hz, 975 
Hz, and 1.5-2.0, respectively.18-24 The lower 
value of HRV was attributable to the autonomic 
nervous imbalance in ACS,8-11,25 which in turn 
played a role in patients’ prognosis;8-13,26,27 The 
decrease in convalescence HRV value was 
associated with non-SCD complications28 while 
the decrease in early HRV value was associated 
with SCD.29
Major adverse cardiac events (MACE) 
occured in 18.7% of ACS patients in this study. 
The result is lower than other comparable studies 
in ICCU RSCM (21.6%-29.9%),30,31 but higher 
compared to other studies which used more 
limited criteria of MACE; only death, stroke, and 
repeated revascularization.32 In general, due to 
exclusion of patients which were having MACE 
during 48-hours of hospitalization, the events in 
our study were slightly lower than in other study.33
The events occurred more frequently 
in STEMI (50%) than in NSTEMI (10.7%) 
and UAP (6.8%) patients. Acute heart failure 
(35.7%) and cardiogenic shock (28.6%) were 
the most common MACE, and anterior segment 
involvement was found in 71% event. These 
findings were in accordance with other studies 
when ACS complications were much more 
frequent in anterior STEMI in the form of: 
acute heart failure, cardiogenic shock, and or 
arrhythmias.34-36
We found that LF parameter has AUC of 
0.697 (95% CI, 0.543-0.850) and LF/LH ratio 
has AUC of 0.851 (95% CI, 0.741-0.962), 
and were considered as better predictors for 
MACE incidence during hospilatization than 
any other HRV parameters. This finding is 
consistent with other studies which shown that 
frequency domain parameters (LF, HF, LF/HF) 
had a better predictive value in short-term HRV 
measurement due to their independence to heart 
rate modulation.8,13,24,37
The limitations in discrimination value were 
more readily explained in LF/HF ratio. Formerly, 
increase in LF/HF ratio was considered as a 
state of sympathetic domination, and vice versa. 
Recent studies showed that such assumption 
was far from truth, because: (1) LF was also 
influenced by parasympathetic system and 
sympathetic system played a role in HF; (2) 
changes in one side of autonomic system were 
not always accompanied by other reciprocal 
changes (e.g. sympathetic and parasympathetic 
could be increased simultaneously), and; (3) 
changes in autonomic balance were often not 
linear.37,38 Therefore, the parameter, while 
still related to outcome, could not express 
sympathovagal balance precisely.39
Table 3. MACE proportion in subjects during hospitalization
Event Number of subjects (N=14)
Death (sudden cardiac death) 1 
Fatal arrhythmia
Ventricular tachycardia 2 
Bradycardia 2 
Cardiogenic shock 4 
Acute heart failure 5 
Table 4. AUC of HRV parameters
Variables AUC (95% CI)
Mean HR (times per minute) 0.622 (0.446-0.797)
SDNN (ms) 0.567 (0.380-0.753)
RMSSD (ms) 0.559 (0.396-0.721)
LF (ms2) 0.697 (0.543-0.850)
HF (ms2) 0.446 (0.283-0.610)
Rasio LF/HF 0.851 (0.741-0.962)
HF=high frequency; HR=heart rate; LF=low frequency; 
ms=miliseconds; RMSSD=square root of mean squared 
differences of consecutive normal-to-normal intervals; 
SDNN=standard deviation of normal-to-normal interval
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Additionally, difference in subjects’ 
characteristics was believed as another main 
cause of HRV limitation in this study; this study 
utilized early HRV measurements in the first 48 
hours post-ACS diagnosis in Asian population. 
Ethnicity would influence HRV variance39,40 
and the time of measurement should be as close 
as possible to the time when the diagnosis was 
made (<45 minutes) for better risk stratification.37 
In addition, our subjects had already treated 
with initial ACS therapy in emergency room 
before ICCU admission which would change 
their prognosis. Therefore, a better predictor for 
MACE might be a persistent decrease in HRV 
parameters. Nevertheless, we believed that 
this method has a more realistic and practical 
value for HRV measurement because until now 
there had not been any measurement standard, 
including time of measurement, for HRV 
examination.
The advantages of this study lie in its 
originality. This is the first study assessing 
HRV ability to predict MACE in ACS patients. 
In addition, because we used short-term 
measurement with PPG method in the intensive 
care, this study also emphasizes the practical 
points of HRV. Overall, this study can be vital for 
future studies focusing on clinical applicability 
and modern medical technology.
However, reflecting our result, we recommend 
to take serial measurement with longer follow-
up time to strengthen the prognostic value of 
HRV. We also recommend doing a further study 
in which HRV measurement will be correlated 
with other prognostic factors such as baseline 
heart rate, ejection fraction, etc.
CONCLUSION
The HRV parameters of LF and LF/HF ratio 
have moderate abilities to predict MACE during 
hospitalization in ACS patients. Both parameters 
have better NPV than PPV, which have a cut-off 
89.673 for LF and 1.718 for LF/HF ratio.
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